0

    512600

    ASTALLTD

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ASTAL LABORATORIES LIMITED Share Price Today

    Investment Returns

    Over 1 Month -1.46% Over 3 Months 21.29% Over 6 Months -4.95% Over 1 Year -12.17%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ASTAL LABORATORIES LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 346.10
    • P/E Ratio (TTM) 44.10
    • Beta 0.27
    • Book Value / share 76.13
    • Return on equity 30.10%
    • EPS (TTM) 1.85
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 1.09
    info icon alternate text

    ASTAL LABORATORIES LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 40.92
    Operating Expense 39.51
    Net Profit 1.09
    Net Profit Margin (%) 2.66
    Earnings Per Share (EPS) 0.29
    EBITDA 2.26
    Effective Tax Rate (%) 26.53
    Particulars DEC 2025 (Values in Cr)
    Revenue 52.24
    Operating Expense 49.14
    Net Profit 2.36
    Net Profit Margin (%) 4.51
    Earnings Per Share (EPS) 2.19
    EBITDA 3.58
    Effective Tax Rate (%) 24.60
    Particulars SEP 2025 (Values in Cr)
    Revenue 37.52
    Operating Expense 34.08
    Net Profit 2.58
    Net Profit Margin (%) 6.87
    Earnings Per Share (EPS) 2.40
    EBITDA 3.90
    Effective Tax Rate (%) 25.64
    Particulars JUN 2025 (Values in Cr)
    Revenue 25.33
    Operating Expense 22.59
    Net Profit 2.09
    Net Profit Margin (%) 8.25
    Earnings Per Share (EPS) 2.13
    EBITDA 3.21
    Effective Tax Rate (%) 25.08
    Particulars MAR 2025 (Values in Cr)
    Revenue 23.47
    Operating Expense 19.66
    Net Profit 2.74
    Net Profit Margin (%) 11.67
    Earnings Per Share (EPS) 2.80
    EBITDA 4.22
    Effective Tax Rate (%) 28.57
    Particulars MAR 2026 (Values in Cr)
    Revenue 156.00
    Operating Expense 145.32
    Net Profit 8.12
    Net Profit Margin (%) 5.20
    Earnings Per Share (EPS) 4.76
    EBITDA 12.96
    Effective Tax Rate (%) 25.29
    Particulars MAR 2025 (Values in Cr)
    Revenue 64.23
    Operating Expense 52.38
    Net Profit 8.93
    Net Profit Margin (%) 13.90
    Earnings Per Share (EPS) 9.08
    EBITDA 12.90
    Effective Tax Rate (%) 25.45
    Particulars MAR 2024 (Values in Cr)
    Revenue 23.65
    Operating Expense 22.57
    Net Profit 0.78
    Net Profit Margin (%) 3.29
    Earnings Per Share (EPS) 0.80
    EBITDA 1.13
    Effective Tax Rate (%) 27.52
    Particulars MAR 2023 (Values in Cr)
    Revenue 3.43
    Operating Expense 3.57
    Net Profit 0.02
    Net Profit Margin (%) 0.58
    Earnings Per Share (EPS) 0.04
    EBITDA 0.04
    Effective Tax Rate (%) 66.66
    Particulars MAR 2022 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.23
    Net Profit -0.02
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.04
    EBITDA -0.01
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 32.77
    ROE % 30.10
    ROCE % 34.78
    Total Debt to Total Equity 0.23
    EBITDA Margin 20.08
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 23.71
    ROE % 5.47
    ROCE % 7.56
    Total Debt to Total Equity 0.01
    EBITDA Margin 4.78
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 12.98
    ROE % 0.39
    ROCE % 0.77
    Total Debt to Total Equity 0.00
    EBITDA Margin 1.17
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 12.93
    ROE % -0.39
    ROCE % -0.19
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 12.97
    ROE % 0.19
    ROCE % 0.19
    Total Debt to Total Equity 0.00
    EBITDA Margin 10.00
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.73
    Total Assets 63.34
    Total Liabilities 63.34
    Total Equity 35.99
    Share Outstanding 0
    Price to Book Ratio 2.32
    Return on Assets (%) 14.09
    Return on Capital (%) 18.12
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 6.07
    Total Assets 36.61
    Total Liabilities 36.61
    Total Equity 23.33
    Share Outstanding 0
    Price to Book Ratio 1.72
    Return on Assets (%) 2.14
    Return on Capital (%) 3.32
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.08
    Total Assets 9.90
    Total Liabilities 9.90
    Total Equity 5.17
    Share Outstanding 0
    Price to Book Ratio 2.28
    Return on Assets (%) 0.16
    Return on Capital (%) 0.32
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 5.22
    Total Liabilities 5.22
    Total Equity 5.16
    Share Outstanding 0
    Price to Book Ratio 1.25
    Return on Assets (%) -0.32
    Return on Capital (%) -0.33
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.03
    Total Assets 5.30
    Total Liabilities 5.30
    Total Equity 5.17
    Share Outstanding 0
    Price to Book Ratio 0.67
    Return on Assets (%) 0.11
    Return on Capital (%) 0.12
    Particulars MAR 2025 (Values in Cr)
    Net Income 11.97
    Cash from Operations -12.21
    Cash from Investing -7.81
    Cash from Financing 3.29
    Net change in Cash -17.04
    Free Cash Flow -6.44
    Particulars MAR 2024 (Values in Cr)
    Net Income 1.08
    Cash from Operations -5.54
    Cash from Investing -6.10
    Cash from Financing 17.67
    Net change in Cash 5.99
    Free Cash Flow 0.36
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.03
    Cash from Operations -1.42
    Cash from Investing 1.50
    Cash from Financing 0.00
    Net change in Cash 0.06
    Free Cash Flow -1.42
    Particulars MAR 2022 (Values in Cr)
    Net Income -0.01
    Cash from Operations -0.24
    Cash from Investing 0.23
    Cash from Financing 0.00
    Net change in Cash -0.01
    Free Cash Flow -0.24
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.00
    Cash from Operations -0.18
    Cash from Investing 0.20
    Cash from Financing 0.00
    Net change in Cash 0.01
    Free Cash Flow -0.18
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.09 12.90 1.50 238.25 23.12 38.85
    BLISS GVS PHARMA LTD 503.85 40.50 4.47 5343.64 118.35 552.90
    CIPLA LTD 1429.45 30.34 3.35 115477.45 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 459.95 20.29 3.32 1353.68 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.09 21.74 4.00 238.25 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 534.05 23.94 4.17 1543.97 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8092.00 105.68 23.17 20230.00 7630.00 9850.00
    BLISS GVS PHARMA LTD 503.85 54.47 4.62 5343.64 118.35 552.90

    ASTAL LABORATORIES LIMITED shareholding pattern

    Holding
    95.46%
    4.53%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    ASTAL LABORATORIES LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    79.03 -3.12 redarrow
    red-green-graph indicator
    13 Bearish
    3 Bullish
    • 5 Days 82.90
    • 26 Days 81.60
    • 10 Days 83.00
    • 50 Days 79.20
    • 12 Days 83.00
    • 100 Days 78.10
    • 20 Days 82.30
    • 200 Days 79.90
    82.55 PIVOT
    First Support 80.53 First Resistance 83.60 Second Support 79.48 Second Resistance 85.62 Third Support 77.46 Third Resistance 86.67
    RSI 50.23 ADX 35.39 MACD 1.40 Williams % R -72.44 Commodity Channel Index (CCI) -32.87
    Date 2026-07-16 Week 11992.00 Same Day 4428.00 Month 24096.00
    1 Year 0.28 3 Year 0.29
    Over 1 Month
    -1.46% down
    Over 1 Year
    -12.17% down
    Over 3 Months
    21.29% down
    Over 3 Years
    46.22% down
    Over 6 Months
    -4.95% down
    Over 5 Years
    53.57% down

    ASTAL LABORATORIES LIMITED Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Astal Laboratories Ltd?

    Answer Field

    Astal Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 79.03 as on Jul 17 2026 03:30 PM.

    What is the Market Cap of Astal Laboratories Ltd Share?

    Answer Field

    The market cap of Astal Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 346.10 as on Jul 17 2026 03:30 PM.

    What is the 52 Week High and Low of Astal Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Astal Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 103.20 and ₹ 60.45.

    What is 1 year return for Astal Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been -12.17%.

    What is the P/E Ratio of Astal Laboratories Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM the price-to-earnings (PE) ratio for Astal Laboratories Ltd share is 44.10.

    What is the PB ratio of Astal Laboratories Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM, the price-to-book (PB) ratio for Astal Laboratories Ltd share is 76.13.

    How to Buy Astal Laboratories Ltd Share?

    Answer Field

    You can trade in Astal Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Astal Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Astal Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Astal Laboratories Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |